Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Pellegatti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|January 3, 2014
Author's responseMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|May 28, 2013
Dogs and monkeys in preclinical drug development: the challenge of reducing and replacingMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|January 18, 2012
Preclinical in vivo ADME studies in drug development: a critical reviewMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|November 7, 2014
The debate on animal ADME studies in drug development: an updateMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|January 19, 2011
Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a reviewMario Pellegatti, Sabrina Pagliarusco
Expert Opinion on Drug Metabolism & Toxicology|June 4, 2011
Plasma protein binding and blood-free concentrations: which studies are needed to develop a drug?Mario Pellegatti, Sabrina Pagliarusco, Lara Solazzo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 13, 2010
Metabolic disposition of casopitant, a potent neurokinin-1 receptor antagonist, in mice, rats, and dogsLidia Miraglia, Sabrina Pagliarusco, Ellenia Bordini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2010
Casopitant: in vitro data and SimCyp simulation to predict in vivo metabolic interactions involving cytochrome P450 3A4Paola Motta, Nicoletta Pons, Sabrina Pagliarusco, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 8, 2009
Disposition and metabolism of radiolabeled casopitant in humansMario Pellegatti, Ellenia Bordini, Patrizia Fizzotti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 28, 2010
Tissue distribution and characterization of drug-related material in rats and dogs after repeated oral administration of casopitantSabrina Pagliarusco, Silvia Martinucci, Ellenia Bordini, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|January 3, 2014
Author's responseMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|May 28, 2013
Dogs and monkeys in preclinical drug development: the challenge of reducing and replacingMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|January 18, 2012
Preclinical in vivo ADME studies in drug development: a critical reviewMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|November 7, 2014
The debate on animal ADME studies in drug development: an updateMario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology|January 19, 2011
Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a reviewMario Pellegatti, Sabrina Pagliarusco
Expert Opinion on Drug Metabolism & Toxicology|June 4, 2011
Plasma protein binding and blood-free concentrations: which studies are needed to develop a drug?Mario Pellegatti, Sabrina Pagliarusco, Lara Solazzo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 13, 2010
Metabolic disposition of casopitant, a potent neurokinin-1 receptor antagonist, in mice, rats, and dogsLidia Miraglia, Sabrina Pagliarusco, Ellenia Bordini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2010
Casopitant: in vitro data and SimCyp simulation to predict in vivo metabolic interactions involving cytochrome P450 3A4Paola Motta, Nicoletta Pons, Sabrina Pagliarusco, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 8, 2009
Disposition and metabolism of radiolabeled casopitant in humansMario Pellegatti, Ellenia Bordini, Patrizia Fizzotti, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 28, 2010
Tissue distribution and characterization of drug-related material in rats and dogs after repeated oral administration of casopitantSabrina Pagliarusco, Silvia Martinucci, Ellenia Bordini, et al.
Pageof 2